InspireMD, Inc. (NSPR) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US45779A8466
InspireMD, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 8.98 m USD |
| Gross profit | 2.65 m USD |
| Operating income | -49.61 m USD |
| EBIT | -48.72 m USD |
| Net income | -48.79 m USD |
| Diluted EPS – continuing operations | -0.76 USD |
Full history since 2008, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About InspireMD, Inc.
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
More stocks
- Raphael Pharmaceutical Inc. (RAPH)
- Black Hawk Acquisition Corp (BKHA)
- PARKS AMERICA, INC (PRKA)
- Creatd, Inc. (CRTD)
- FORUM MARKETS Inc (FRMM)
- Western Alaska Minerals Corp (WAM.V)
- Cell Source, Inc. (CLCS)
- JONES SODA CO. (JSDA)
- SEAFARER EXPLORATION CORP (SFRX)
- RAVE RESTAURANT GROUP, INC. (RAVE)
- Paradium AI, Inc. (PAAI)
- HARTE HANKS INC (HHS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.